Biophysical Society Selects 2009 Distinguished Service, Emily M. Gray And Society Fellow Recipients The Biophysical Society is pleased to announce the recipients of its 2009 Distinguished Service Award and the Emily M. Gray Award, as well as the Society's 2009 Fellows. All of the award winners and Fellows will be recognized at the Awards Ceremony during the Biophysical Society's 53rd Annual Meeting on Monday March 2, 2009 at the Boston Convention and Exhibition Center in Boston, Massachusetts.
Source: www.medicalnewstoday.comCircadin(R), A Novel First In Class Insomnia Medication Now Available In Poland, Hungary And Czech Republic Lundbeck has entered the sleep disorder market in Eastern Europe with three consecutive launches of first in class insomnia medication, Circadin® in Poland, Hungary and Czech Republic. Circadin®, a sustained-release melatonin, is indicated as monotherapy for the short-term treatment of primary insomnia in patients who are aged 55 or over.
Source: www.medicalnewstoday.comCDC Advisory Panel Votes To Update Pneumococcal Vaccination Recommendations The U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously yesterday to recommend that adults ages 19 to 64 with asthma receive pneumococcal polysaccharide vaccine (PPSV23), known as PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent). Merck & Co., Inc. is the sole supplier of PNEUMOVAX 23 in the United States.
Source: www.medicalnewstoday.comInsomnia - EMEA Issues Positive Opinion For LUNIVIA(R) (Eszopiclone) Marketing Authorization Application (MAA) In Europe Sepracor Inc. (Nasdaq: SEPR) today announced that the EMEA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending to grant a marketing authorization for LUNIVIA® brand eszopiclone in the European Union (EU) for the treatment of insomnia.
Source: www.medicalnewstoday.comUnique Research Partnership Announced By GUMC And Oak Ridge National Labs Georgetown University Medical Center and Oak Ridge National Laboratory have announced an agreement between the institutions that formalizes their research relationship and will help facilitate additional biomedical research - particularly in the areas of structural biology, systems genetics, biomarkers, computational biology, and radiation biology.
Source: www.medicalnewstoday.comCancer Drug Vidaza(R) Receives Positive Opinion From European Regulatory Authority For Treatment Of MDS And AML The positive opinion includes important survival data from the AZA-001 trial in higher-risk MDS patients. The CHMP, which reviews applications for all 27 Member States in the European Union (EU) as well as Norway and Iceland, has recommended approval for azacitidine.
Source: www.medicalnewstoday.comNew Steps Uncovered On Pathway To Enlarged Heart Researchers have new insight into the mechanisms that underlie a pathological increase in the size of the heart. The research, published by Cell Press in the October 24th issue of the journal Molecular Cell, may lead to the development of new strategies for managing this extremely common cardiac ailment that often leads to heart failure.
Source: www.medicalnewstoday.comErikson Institute Herr Research Center To Host Policy Conference On Trends And Needs In Early Childhood Mental Health Systems Erikson Institute's Herr Research Center for Children and Social Policy this week will host leading child advocates, researchers, and state officials from Illinois, Michigan, and Wisconsin to discuss mental
health services for children and infants.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
